Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$0.19 - $0.42 $4,499 - $9,945
-23,680 Reduced 52.6%
21,336 $4,000
Q2 2023

Jul 27, 2023

BUY
$0.34 - $1.09 $6,274 - $20,113
18,453 Added 69.47%
45,016 $16,000
Q1 2023

May 01, 2023

BUY
$0.34 - $1.89 $9,031 - $50,204
26,563 New
26,563 $21,000
Q2 2022

Aug 09, 2022

BUY
$0.67 - $1.51 $11,002 - $24,797
16,422 New
16,422 $13,000

About Hillstream BioPharma Inc.


  • Ticker HILS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 11,529,900
  • Market Cap $33.2M
  • Description
  • Hillstream BioPharma, Inc., a pre-clinical biotechnology company, develops novel therapeutic candidates targeting ferroptosis, an anti-cancer mechanism resulting in iron mediated cell death (IMCD) for the treatment resistant cancers. The company's product candidate is HSB-1216, an IMCD inducer targeting solid tumors. It also develops HSB-888, a ...
More about HILS
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.